Results 241 to 250 of about 52,183 (303)

Disease Modification of Pustular Psoriasis by Secukinumab: A 20‐Year Follow‐Up of Von Zumbusch‐Type Generalized Pustular Psoriasis With Evolution Into Annular Pustular Psoriasis—A Case Report

The Kaohsiung Journal of Medical Sciences, Volume 42, Issue 1, January 2026.
Yu‐Han Alice Hsu, Cheng‐Che E. Lan, Sheng‐Yiao Lin   +2 more
wiley   +1 more source

Drug-Induced Phototoxicity in Vitiligo: The Role of Hydrochlorothiazide in Photosensitivity Dermatitis. [PDF]

Case Rep Dermatol Med
Parga AD, Dubin C, Rudikoff D.
europepmc   +1 more source

Cutaneous Adverse Effects of EGFR Therapy in Breast Cancer Treatment. [PDF]

Clin Transl Sci
Devireddy T, Lim C, Patel J, Tan IJ, Cohen BA.   +4 more
europepmc   +1 more source

Famotidine-Induced Rash and Eosinophilia: A Case Report. [PDF]

Cureus
Junaid A, Graggaber J.
europepmc   +1 more source

Dapsone Hypersensitivity Syndrome in Leprosy. [PDF]

Am J Trop Med Hyg
Sagar HK.
europepmc   +1 more source

Levetiracetam-Aggravated Severe Treatment-Resistant Acne. [PDF]

Indian Dermatol Online J
Kothari R, Manoj R, Singh S, Gupta A.
europepmc   +1 more source

Acyclovir‐unresponsive disseminated herpes zoster in B‐cell chronic lymphocytic leukemia

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, Volume 24, Issue 1, Page 87-90, January 2026.
Tabael L. Turan, Thomas K. Eigentler, Ulrike Blume‐Peytavi, Kamran Ghoreschi   +3 more
wiley   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Eczematous Drug Eruptions

American Journal of Clinical Dermatology, 2021
Eczematous drug eruptions are a heterogenous group of skin reactions that resemble eczema both clinically and histologically. We reviewed the literature and cataloged the systemically administered medications that cause these eruptions, along with their characteristic clinical presentations.
Amy E. Blum, Susan Burgin
openaire   +2 more sources